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Plateletsmayplay a role in the pathogenesis of human cerebralmalaria (CM), and theyhave been shown to induce
clumping of Plasmodium falciparum–parasitized red blood cells (PRBCs) in vitro. Both thrombocytopenia and
platelet-inducedPRBCclumpingare associatedwith severemalaria and, especially,withCM. In thepresent study,
we investigated the occurrence of the clumping phenomenon in patients with CM by isolating and coincubating
their plasma and PRBCs ex vivo. Malawian children with CM all had low platelet counts, with the degree of
thrombocytopenia directly proportional to the density of parasitemia. Plasma samples obtained from these pa-
tients subsequently induced weak PRBC clumping.When the assays were repeated, with the plasma platelet con-
centrations adjusted to within the physiological range considered to be normal, massive clumping occurred. The
results of this study suggest that thrombocytopenia may, through reduction of platelet-mediated clumping of
PRBCs, provide a protective mechanism for the host during CM.
Severe malaria is a major cause of death in sub-Saharan
African children. A pathological characteristic that is
common to the diverse life-threatening syndromes that
can result from Plasmodium falciparum infection is the
sequestration of large numbers of mature parasitized red
blood cells (PRBCs) within the microvasculature of vital
organs. Sequestration is generally attributed to cytoad-
herence of PRBCs on microvascular endothelial cells
[1]. However, postmortem studies have shown that in-
travascular PRBCs are not adjacent to the vascular en-
dothelium [2], suggesting that some PRBCs may be ad-
herent to each other rather than to the vascular
endothelium and that they might have accumulated
through a process of adhesion between PRBCs.
Platelet accumulation can be found in the cerebral
microvessels of patients who died of cerebral malaria
(CM) but not in those of patients who died of severe
malarial anemia (SMA), suggesting a possible role for
platelets in the pathogenesis of cerebral CM [3]. Platelets
can mediate the formation of PRBC clumps in vitro [4].
This phenomenon has been shown to be more common
when parasites from patients with severe malaria, rather
than isolates from patients with mild malaria, are used,
both in Kenyan children [4] and in Thai adults [5]. The
size of the clumps observed in vitro is sufficient to be
responsible for important rheological disturbances in
infected patients, if the clumps are similarly sized in
vivo.
Thrombocytopenia is a typical characteristic of P. fal-
ciparum infection. The degree of thrombocytopenia was
found to correlate with the risk of a fatal outcome in one
study [6] but not in another [7]. We postulated that the
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presence of abnormally low numbers of circulating platelets in
patients with malaria would restrict the formation of platelet-
PRBC aggregates, an effect that might limit the severity of cere-
bral pathology.
PATIENTS AND METHODS
Patients. We studied consecutively observed cases of uncom-
plicated malaria (UM), SMA, and CM in patients who were ad-
mitted to the pediatric research ward of the Queen Elizabeth
Central Hospital in Blantyre, Malawi. The clinical characteristics
of these patients are detailed in table 1. All patients with UM and
SMA had P. falciparum parasitemia and were conscious (Blan-
tyre coma score, 5 [of a possible 5]). These patients were consid-
ered to have UM if the packed cell volume was25% and SMA
if it was12%. Patients with CM were admitted to the hospital
in a coma (Blantyre coma score,2), had P. falciparum parasi-
temia, and had no other clinically evident cause of unconscious-
ness. All of the patients with CM who were included in the
present study showed evidence of malarial retinopathy, a re-
cently described finding that improves the accuracy of the clin-
ical diagnosis of CM (for review, see [8]). The patients’ relatives
provided fully informed consent to participate in the study, and
a 2.5-mL blood sample was taken for parasite culture and sepa-
ration of plasma and platelets. The studies were approved by the
ethics review committees of the College of Medicine, University
of Malawi (Blantyre); the Liverpool School of Tropical Medicine
(Liverpool, United Kingdom); and Michigan State University
(East Lansing).
Parasite culture. Blood samples from patients were col-
lected in sodium citrate tubes and centrifuged at 250 g for 10
min. Plasma was stored at 4°C, and pelleted RBCs were washed 3
times in RPMI 1640 and then were resuspended in a standard
malaria culture medium of RPMI 1640 supplemented with 25
mmol/L HEPES, 10% fetal calf serum, and 40 mg/mL gentami-
cin, to achieve a final hematocrit of 5%. After cultivation at 37°C
in 5% CO2 for up to 48 h, the parasite stages and numbers were
adjusted to a 10% mature-form (the pigmented trophozoite
stage) parasitemia by means of gelatin flotation, to standardize
the assays and compare the results. Blood smears were then pre-
pared, and the stage of parasite maturation was examined by
microscopy.
Preparation of platelet-rich plasma (PRP) and platelet-
poor plasma (PPP). PRP and PPP were extracted from 5 mL
of whole blood provided by malaria-naive donors or from 2.5
mL of whole blood obtained from patients with CM. Blood was
collected in a sodium citrate tube and centrifuged at 250 g for 10
min. The PRP fraction was then transferred to a new tube, and a
platelet count was performed with Neubauer’s hematocytom-
eter before storage. PPP was obtained by further centrifugation
performed at 1500 g for 10 min to discard platelets, and both
PRP and PPP were stored at 4°C and used within 4 days.
Clumping assays. Clumping kinetics (figure 1A) were as-
sessed when the parasites had grown to the stage of pigmented
trophozoites and were selected as described above. Parasite cul-
tures labeled by the addition of 20 mg/mL acridine orange were
then rotated in 5% hematocrit in the presence of 20% PPP
(platelet count, 10 platelets/L) or 20% PRP (platelet count,
300  103 platelets/L [for healthy donors] or 150  103
platelets/L [for patients with CM]). After 15 min of rotation, 25
L of sample was obtained, placed on a glass slide, and examined
by fluorescent microscopy. Additional samples were obtained at
30, 60, and 120 min, as described elsewhere [4]. A “clump” was
defined as 3 infected erythrocytes, and the frequency of the
clumping phenotype in isolates was measured as the number of
infected cells in clumps among 1000 infected cells counted in
duplicate assays. For the autoassays (figure 1B), PRP, PPP, and
cultured parasites isolated from the same patient with CM were
used (in vivo platelet count,150  103 platelets/L). Platelet
numbers were concentrated 5 times in plasma samples used for
autoassays, so that, when mixed with parasite suspensions, the
final concentration of platelets would be representative of the in
vivo conditions. Platelet concentration was accomplished by
gentle centrifugation, removal of a calculated portion of plasma,
and resuspension of platelets. To assess the potential influence of
plasma factors on clump formation, the same technique was
used to adjust several platelet suspensions to a final average
Table 1. Clinical and laboratory characteristics of Malawian children with acute Plasmodium falciparum malaria.
Characteristic
Patients with UM
(n  12)
Patients with SMA
(n  15)
Patients with CM
(n  22)
Age, median (IQR), months 55.5 (29–82.5) 45 (30–82) 36.5 (18–63)
Blantyre coma score, median (range) 5 5 1 (0–3)
Parasitemia, geometric mean (95% CI),
parasites/L 23,617 (8910–62,560) 99,550 (63,400–156,300) 68,700 (27,750–171,300)
Platelet count, median (IQR), 103 cells/L 67 (37.5–232.5) 97.2 (72–124)a 58 (21–145.5)a
Spearman’s correlation testb (P value) 0.3916 (.05) 0.1055 (.05) 0.675 (.001)
NOTE. CI, confidence interval; CM, cerebral malaria; IQR, interquartile range; SMA, severe malarial anemia; UM, uncomplicated malaria.
a Thrombocytopenic groups: a patient was considered to have thrombocytopenia when his/her platelet count was 150  103 cells/L.
b For assessment of the correlation between the platelet count and parasitemia.
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count (300  103 platelets/L). Clumping assays were then
performed according to the protocol for classic assays described
above.
Analysis of platelet activation in clumps. Variation of
platelet membrane P-selectin expression was measured by im-
munofluorescence on slides and by flow cytometry. Both were
performed on platelets alone in PRP obtained from patients with
CM, as well as on clumps after 2 min of coincubation of PRP
with PRBCs. For the immunofluorescence studies, PRP alone or
PRP after coincubation in clumping assays was incubated at
room temperature for 20 min with fluorescein isothiocyanate–
coupled mouse anti– human CD62-P (P-selectin, clone
JMCD62P; Orbigen) before observation with the use of a fluo-
rescence microscope. Flow cytometric analyses required clumps
of small or medium size, and the antibody was added, either 5
min before PRP analysis or after 2 min of PRP-PRBC coincuba-
tion, for 5 min. In the latter case, the total of 7 min of coincuba-
tion led to the formation of clumps of the desired dimension.
Inhibition of platelet-induced clumping by monoclonal
antibodies. PRP samples were incubated at 37°C for 1 h with
several blocking antibodies against platelet membrane glycopro-
teins, such as CD36 (GPIV, clone FA6-152; Beckman Coulter
Immunotech), P-selectin (CD62-P, clone AK-6; Serotec),
GPIIb/IIIa (CD41/CD61 chimeric antibody, clone 7E3 [ReoPro;
Centocor]; a gift from G. Wiemann), or IgG isotype control.
Lamifiban (Ro44-9883; Roche) (provided by Jürgen Fingerle of
F. Hoffmann–La Roche), a peptidomimetic synthetic GPIIb/IIIa
inhibitor, was also incubated with PRP for the same length of
time. PRP was then used in clumping assays performed as pre-
viously described.
Statistical analysis. Statistical analyses were performed us-
ing Stata software (version 8.1; Stata). Data were analyzed using
the Mann-Whitney U test to compare pairs of groups. Results
were expressed as the mean value (SD) for individual experi-
mental groups, and the clumping data for the different patient
groups were analyzed using the Kruskal-Wallis test and Dunn’s
pairwise test. The correlation between parasite density and plate-
let count in table 1 was assessed using Spearman’s correlation
test. P  .05 was considered to be statistically significant.
RESULTS
Association of platelet-induced PRBC clumping phenotype in
children with severe malaria in Malawi. We assessed the
occurrence of the previously described platelet-induced in vitro
PRBC clumping phenomenon in Malawian children with P. fal-
ciparum malaria. Parasites isolated from 49 patients were stud-
ied; 12 of these 49 patients had UM, and, of the 37 patients who
had severe malaria, 15 had SMA and 22 had CM (table 1). In the
presence of PPP from healthy donors, no PRBC autoagglutina-
tion was observed in any of the patient groups after coculture for
120 min (figure 2A–2C). When incubation with PRP was per-
formed, however, the platelet-induced clumping phenotype was
observed in all groups. This phenomenon was time dependent
and was associated with disease severity and type. Parasites iso-
lated from patients with UM showed a weak ability to aggluti-
nate in the presence of platelets, with 27.1% 12.0% of clumped
PRBCs present at the end of the kinetics studies.
Microscopic analysis showed, for cases of UM, a homoge-
neous suspension of PRBC, with some small clumps (8.6  3.0
PRBCs/clump) randomly distributed (figure 2A). For cases of
SMA or CM, autoagglutination was significantly higher than
that noted for cases of UM (at 60 min and after for SMA
[P  .05 at 60 min;P  .001 for all of the other times] and at 15
min and after for CM [P  .001 for each kinetics point]).
For SMA, clumped PRBCs constituted 59.1% 14.1% of the
total PRBC population at the end of the kinetic study, and
significantly larger clumps were observed for SMA than for
UM (42.9  9.5 vs. 6.5  4.3 PRBCs/clump, respectively)
(P  .001) (figure 2B). In the presence of platelets, parasites
isolated from patients with CM exhibited a statistically stronger
clumping phenotype than did parasites from patients with SMA
(P  .001, for each kinetics point), leading to the formation of
giant clumps (50 PRBCs/clump) within the first 15 min of
incubation and to the aggregation of all of the PRBCs in the
suspension. The number of PRBCs could not be counted pre-
Figure 1. Schematic representation of clumping assays. Classic
clumping assays were performed as described elsewhere [4, 5], with the
use of parasites that were isolated from infected patients, cultured, and
incubated with platelet-poor plasma (PPP) and platelet-rich plasma (PRP)
obtained from healthy donors with a normal platelet count (A). In
autoassays, parasites, PPP, and PRP were all obtained from the same
patient, to assess the potential for occurrence of this phenomenon ex
vivo (B). CM, cerebral malaria; SMA, severe malarial anemia; UM,
uncomplicated malaria.
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cisely in giant clumps, but some clumps contained up to 125
PRBCs (figure 2C). In each experiment, we used as controls un-
infected erythrocytes isolated from healthy and malaria-naive
donors, all of whom exhibited platelet counts within the range
considered to be normal (150  103 to 450  103 platelets/
L). Cells were incubated with PPP or PRP that was obtained
and processed as described in the experimental procedures, and
aggregation was never observed (data not shown).
Involvement of platelet activation and subsequent up-
regulation of P-selectin in the clumping effect. To assess
platelet activation during clumping, we used immunofluores-
cent staining to identify P-selectin on platelets both before and
after 10 min of coincubation with PRBCs. Samples were ana-
lyzed using fluorescent microscopy and flow cytometry. Before
coincubation with PRBCs, platelets obtained from patients with
CM did not show any sign of activation: they were of normal
circular shape (figure 3A). Flow cytometric analysis showed that
the gated platelet population had low P-selectin surface expres-
sion, with a mean fluorescence intensity (MFI) of 5.8% (figure
3C and 3E). Within 10 min of the addition of PRBCs, platelets
exhibited typical activation pseudopodia (figure 3B), and signif-
icant up-regulation of membrane P-selectin was observed for
the platelet and clump populations, reaching an MFI of up to
77.4% (figure 3D and 3F). Platelets not associated with clumps
(figure 3D, gate [p]) exhibited an increased MFI of 49.9% (data
not shown). A control experiment was performed by mixing
unparasitized erythrocytes with PRP, and neither platelet
changes nor uninfected erythrocyte clumping was observed
(data not shown).
To investigate the potential role of platelet P-selectin as a re-
ceptor for PRBC in this aggregation phenomenon, PRP was then
incubated in the presence of blocking anti–P-selectin, as well as
several other antibodies or antagonists against the platelet mem-
brane glycoproteins listed above, before undergoing incubation
with PRBCs isolated from patients with CM. In the presence of
anti–P-selectin, platelet-induced PRBC clumping was signifi-
cantly but partially decreased, with 20.7%  11.0% inhibition
(P  .001), compared with clumping noted for controls (figure
3E). Incubation with anti-CD36 led to a dramatic reduction in
aggregation (67.3%  6.5%; P  .01), as described elsewhere
[4], and a combination of both antibodies led to almost com-
plete abrogation of clumping, with greater inhibition than the
additive effect of the antibodies taken separately (97.7% 
10.5%; P  .01). By contrast, the blocking of the platelet surface
glycoproteins GPIIb and IIIa by high concentrations of ReoPro
or Lamifiban (1–30 g/mL and 50 –100 ng/mL, respectively),
agents that are both known to block platelet aggregation [9],
failed to induce significant inhibition of PRBC aggregation
(P  .05) (figure 3E). When platelets were inactivated by pre-
treatment with heparin to inhibit the up-regulation of P-selectin
on their surface (1000 U/mL), the same level of inhibition re-
ported for anti–P-selectin treatment was observed (data not
shown).
Figure 2. Ability to form clumps (defined as3 parasitized red blood cells [PRBCs]) in the presence of platelets in parasite populations isolated from
pediatric patients in Malawi. Platelet-induced PRBC clumping is a common parasite phenotype among Malawian children and is associated with disease
severity. Parasites isolated from patients with uncomplicated malaria (n  12), severe malaria anemia (n  15), and cerebral malaria (n  22) were
incubated for different times with plasma with or without platelets. Results are expressed as the mean percentage ( SD) of PRBCs associated with
clumps. Assays were performed twice for each patient sample.
Thrombocytopenia and Clumping in CM ● JID 2008:197 (1 January) ● 75
Restriction of ex vivo clump formation by thrombocytope-
nia in patients with CM. The occurrence of clump formation
ex vivo in the presence of thrombocytopenia was then evaluated
by the use of PRP and PRBCs from the same patient with CM.
Healthy donors who provided the PRP used in previous assays
exhibited an average platelet count of300  103 platelets/L,
whereas all 22 patients with CM had thrombocytopenia, with
platelet counts of 150  103 platelets/L at admission (table
1). When incubated with PRP from the same patient with
thrombocytopenia, PRBCs showed a significantly reduced
clumping phenotype (mean percentage of reduction [ SD] af-
ter a 120-min incubation step, 39.6%  19.4%). To assess
whether this clumping restriction was due only to the low plate-
let count and not to other circulating plasma factor(s) in these
patients with CM, we adjusted the PRP to a final average platelet
count of 300  103 platelets/L, by use of a low-
centrifugation step as described above. When PRP with an ad-
justed platelet count was incubated with PRBCs, there was a
partial but significant restoration of the clumping, reaching
82.6%  11.6% after 120 min (P  .001) (figure 4). A control
experiment performed with PRP obtained from healthy donors
with a platelet count adjusted to disease-type concentration by
dilution (60  103 platelets/L, as calculated in table 1) led to a
significant decrease in clumping (data not shown).
Correlation of the degree of thrombocytopenia with the
density of parasitemia in patients with CM in Malawi. The
association between the platelet count and the density of parasi-
temia was investigated in the 3 patient categories (table 1). A
negative coefficient of correlation (0.675) was found between
these 2 variables in the CM group, with Spearman’s correlation
test showing strong statistical significance (P  .001). This as-
sociation was not observed in patients with SMA or UM.
DISCUSSION
In the present study, we demonstrated that platelet-mediated
PRBC clumping is a stable and common in vitro phenotype of all
of the P. falciparum strains isolated from 49 infected Malawian
children. We also showed that this phenotype is quantitatively
associated with disease severity and type, that the platelet mole-
cules responsible for this effect are CD36 and P-selectin, and that
the degree of thrombocytopenia present in patients with CM is
sufficient to limit the further formation of PRBC clumps in vitro.
The aims of the present study were, first, to document the
occurrence of the platelet-induced PRBC clumping phenome-
non in parasites isolated from Malawian pediatric patients and,
second, to assess its association with disease severity and type
(UM vs. severe malaria, as well as SMA vs. CM). We demon-
strated clumping of PRBCs in the presence of PRP for all isolates
recovered from patients with malaria who were admitted to the
ward, irrespective of their clinical syndrome. The ability to gen-
erate clumps in the presence of a standard preparation of plate-
Figure 3. P-selectin expressed by activated platelets and CD36 acting as
a major receptor for parasitized red blood cell (PRBC) clumping. Platelet
activation was measured before and after coincubation with PRBCs. The level
of membrane P-selectin expression was assessed by immunofluorescence
performed on slides (A and B ) and by flow cytometry (C, D, E, and F ). The
micrographs, dot plots, and histograms shown present the results observed
for 4 assays. The addition of PRBCs resulted in the generation of a platelet-
PRBC clump population observed in dot plot D, and the platelet population
that was not associated with PRBCs was subgated in [p]. Inhibition assays
were then performed to evaluate the role of P-selectin and several other
platelet surface molecules in the parasite clumping phenomenon (G). Platelet-
rich plasma (PRP) obtained from healthy donors was incubated with either
IgG (control; 10 g/mL), anti–P-selectin (20 g/mL), anti-CD36 (10 g/mL),
a mixture of both anti–P-selectin and CD36 (stated as “Mix”), ReoPro
(Centocor; 30 g/mL), or Lamifiban (100 ng/mL) before being used in clump-
ing assays with PRBCs from patients with cerebral malaria (CM). Histograms
express the mean percentage (SD) of PRBCs associated with clumps after
120 min. The Mann-Whitney U test was used to compare pairs of groups,
and P  .05 was considered to be statistically significant. Assays were
performed twice for each sample obtained from a patient with CM. FITC,
fluorescein isothiocyanate. FS, form scatter; SS, size scatter.
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lets was significantly greater in P. falciparum isolates recovered
from patients with severe disease (i.e., SMA and CM) than in
parasites isolated from patients with uncomplicated illness.
These results are consistent with results of previous studies in-
volving Kenyan children [4] and Thai adults [5].
In the present study, the tendency to generate clumps was also
shown to be significantly greater with CM isolates than with
SMA isolates, indicating an association between the clumping
phenotype and the disease syndrome. Whether this association
is causal—that is, whether clumping contributes directly to
pathogenesis—remains to be studied. For patients with CM, the
addition of PRP to parasite cultures led to the formation of large
clumps within only 20 min of incubation. The giant clump for-
mation that we observed in vitro as a consequence of platelet and
PRBC adhesion in patients with CM may, if it occurs in vivo,
result in the increased accumulation of PRBCs within the micro-
vasculature of patients with CM, compared with that of patients
with other malarial syndromes [10]. The recently described ac-
cumulation of platelets within the cerebral venules of Malawian
patients with CM supports this hypothesis. Several patterns of
platelet distribution have been demonstrated by means of per-
oxidase immunostaining of cerebral tissue, some of which in-
clude platelets clustered between parasite pigment in the whole
length of visible vessels [3], suggesting a clumping between
platelets and PRBCs. Platelets may also directly contribute to the
adhesion of PRBCs to activated endothelium [11]. Uneven dep-
osition of platelets may contribute to the observed disparate dis-
tribution of sequestration in the microvasculature of patients
with CM [12].
We then further analyzed the role of platelet activation in the
formation of clumps. Previous studies have shown that PRBCs
are able to activate platelets [13, 14], leading to the immediate
transfer of the internal P-selectin (stocked in the platelet  gran-
ules) to its surface [15]. Because the presence of P-selectin has
been described as a synergistic factor in the binding of PRBCs on
endothelial CD36 [16], we hypothesized that platelet P-selectin
was likely to be involved in clump formation. Its expression on
platelet membranes increased dramatically during clumping,
confirming that platelets are activated by PRBCs. We also dem-
onstrated, by use of inhibition assays, that P-selectin was in-
volved as a PRBC receptor in clump formation.
The other molecule shown to be involved in PRBC-platelet
adherence in the present study was CD36. Both P-selectin and
CD36 are expressed on platelets, and both are known to be re-
ceptors for PfEMP-1, the parasite protein expressed on the sur-
face of PRBCs [17–20]. These findings are consistent with pre-
vious studies [4] of CD36, but P-selectin has not previously been
identified as a receptor mediating platelet-PRBC clumping.
When both CD36 and P-selectin were blocked by antibodies, the
clumping phenomenon was abrogated, and our results suggest
synergism between the 2 receptors during clump formation.
P-selectin has been reported to increase the adherence of
PRBCs to CD36 on endothelium [16], and its substantial but
transient expression on PRBC-activated platelet surfaces may act
as a trigger for the amplification of the clumping phenomenon.
Such a “clumping-activation-clumping” loop might explain the
massive aggregation observed in the early minutes of our assays
with CM-derived PRBCs. Platelet activation as a consequence of
clumping formation in vivo would lead to a massive release of
transforming growth factor–1, which is contained in the plate-
let  granules. This pleiotropic cytokine has recently been de-
scribed to act as an inducer of apoptosis in endothelium in in-
flammatory conditions; platelet activation in sequestration sites
in vivo may therefore make additional indirect contributions to
pathogenesis [14].
Finally, we investigated the possibility of a natural restriction
of clumping associated with thrombocytopenia in patients with
malaria. The formation of giant clumps in vivo could be ex-
pected to lead to important rheological disturbances and mi-
crovessel occlusion, yet in vivo studies have suggested that se-
questration of PRBCs is not sufficient to block brain
microcirculation in patients with CM [1, 21]. Because platelets
seem to be a crucial element in clump generation, we investi-
gated the effect of thrombocytopenia, exhibited by all of our
patients with CM (table 1), on clump formation ex vivo. We
developed a new method of ex vivo coculture of different cell
types (i.e., platelets and PRBCs) isolated from the same patient,
Figure 4. Thrombocytopenia in patients with cerebral malaria (CM)
and restriction of the formation of platelet–parasitized red blood cell
(PRBC) clumps (defined as 3 PRBCs) in vitro. For autoassays, PRBCs
were incubated in the presence of control platelet-poor plasma (PPP)
(open circles) and platelet-rich plasma (PRP) obtained from the same
patient with CM (final platelet count, 150  103 platelets/L) (filled
circles) or in the presence of PRP from the same patient but with a
platelet suspension adjusted to a normal platelet count (final platelet
count,300  103 platelets/L) (filled triangles). Results are expressed
as the mean percentage (SD) of PRBCs that are associated with
clumps. Assays were performed 3 times for each sample obtained from
a patient with CM.
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and we compared the effect of PRP from healthy individuals
(average platelet count,300  103/L) with the effect of PRP
from the same patient (average platelet count,150  103/L)
on clump formation. Plasma from patients with thrombocyto-
penia failed to generate giant clumps, and an adjustment of the
platelet count to within the range considered to be normal in
these plasma samples led to the restoration of the phenomenon.
These results suggest that, in patients with malaria, thrombocy-
topenia may have the potentially beneficial effect of restricting
clump formation in vivo, leading to less platelet activation and,
thereby, modulating pathogenesis.
The degree of thrombocytopenia in pediatric patients with
CM was significantly correlated with parasitemia (Spearman’s
correlation test, 0.675; P  .001) (table 1). A possible expla-
nation for this correlation would be that thrombocytopenia re-
sults from widespread clumping in sequestration sites, the de-
gree of which is directly linked to the parasite burden of the
patient. However, this hypothesis is not supported by experi-
ments in mice in which abrogation of the platelet trapping in
cerebral microvasculature had no effect on the low platelet count
of the animals [22]. Whatever the mechanism of thrombocyto-
penia, it appears that, in human CM, the invariably low platelet
count may function as a protective mechanism for the host.
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